News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Long-term dupilumab blocks relapse in moderate-to-severe atopic dermatitis
25 May 2026
byStephen Padilla
The use of dupilumab significantly delays disease relapse in patients with moderate-to-severe atopic dermatitis (AD) while having an acceptable safety profile, reports a study.








